2009
DOI: 10.1002/pon.1480
|View full text |Cite
|
Sign up to set email alerts
|

Development of a screening tool for the identification of psychooncological treatment need in breast cancer patients

Abstract: Objective: In breast cancer patients the diagnosis, treatment and aftercare of the physical disease cause a large amount of psychosocial distress, which can have a variety of negative consequences on patients' physical and mental well-being. Although about one-third of the patients show heightened psychosocial distress that may require psychooncological interventions its detection in daily clinical routine is poor and referral to mental health professionals is insufficient. The aim of the study was to develop … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
27
0
1

Year Published

2011
2011
2018
2018

Publication Types

Select...
6
2
1

Relationship

2
7

Authors

Journals

citations
Cited by 27 publications
(28 citation statements)
references
References 44 publications
0
27
0
1
Order By: Relevance
“…Effective screening for psychosocial distress can be performed by means of PRO-instruments like the Hospital Anxiety and Depression Scale (HADS) (Zigmond & Snaith, 1983) or the General Health Questionnaire (GHQ-12) (Goldberg, 1972). Approximately 20-40 percent of cancer patients suffer from psychosocial distress and are therefore in need for referral to psychooncological treatment (Meraner et al, 2009 these patients, PROs contribute in the detection of needs for psychooncological treatment and therefore prevent further ailments. As a screening tool is supposed to offer a quick possibility to check for impairments that require treatment, cut-off scores are of major importance.…”
Section: Symptom Monitoring and Screeningmentioning
confidence: 99%
See 1 more Smart Citation
“…Effective screening for psychosocial distress can be performed by means of PRO-instruments like the Hospital Anxiety and Depression Scale (HADS) (Zigmond & Snaith, 1983) or the General Health Questionnaire (GHQ-12) (Goldberg, 1972). Approximately 20-40 percent of cancer patients suffer from psychosocial distress and are therefore in need for referral to psychooncological treatment (Meraner et al, 2009 these patients, PROs contribute in the detection of needs for psychooncological treatment and therefore prevent further ailments. As a screening tool is supposed to offer a quick possibility to check for impairments that require treatment, cut-off scores are of major importance.…”
Section: Symptom Monitoring and Screeningmentioning
confidence: 99%
“…Next to treatment-related symptoms, cancer patients have also to deal with psychosocial distress triggered by the disease itself and anti-cancer therapy. Since the inadequate or missing treatment of psychosocial distress may confront the patient with further impairments, as they might develop chronic mental disorders, early detection of psychosocial distress is necessary (Meraner et al, 2009). Effective screening for psychosocial distress can be performed by means of PRO-instruments like the Hospital Anxiety and Depression Scale (HADS) (Zigmond & Snaith, 1983) or the General Health Questionnaire (GHQ-12) (Goldberg, 1972).…”
Section: Symptom Monitoring and Screeningmentioning
confidence: 99%
“…We considered three alternative tools for administering the questionnaire. The first one is CHES (Computer-based Health Evaluation System) [8], a tablet-based application where the users, using a stylus instead of a pen, enter their replies by performing the same actions required by the paper-based form (see Figure 1).…”
Section: Quality Of Life Questionnaire Fillingmentioning
confidence: 99%
“…CHES (Computer-based Health Evaluation System) is an innovative application used to collect data about the psychological and physical status of patients [11]. CHES allows the clinicians to submit to their patients standardized questionnaires, as that on the "Quality of Life" [12] and to automatically elaborate their answers into consistent indicators on their health status.…”
Section: B Architecturementioning
confidence: 99%